PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
05-Dec-2019 Astellas and MBC BioLabs Announce Golden Ticket Winners - Supporting Biotech Start-Ups to Accelerate Innovative Science Astellas
05-Dec-2019 Lessons from EU Medical Device Regulation compliance preparations Kallik
05-Dec-2019 Internet of Medical Things - the Latest Developments SMi Group Ltd
05-Dec-2019 Biologics Market Size to Upsurge Based on Increasing Occurrence of Long-Lasting Sicknesses Till 2025 | Million Insights Million Insights
05-Dec-2019 Ardelyx Announces Pricing of Upsized Public Offering of Common Stock Ardelyx
04-Dec-2019 RubrYc Therapeutics Announces formation of its Scientific Advisory Board RubrYc Therapeutics, Inc.
04-Dec-2019 Benchling Joins the AWS Partner Network Global Startups Program Benchling
04-Dec-2019 New global survey shows misperceptions about lung cancer among the general public Lung Ambition Alliance
04-Dec-2019 ASLAN PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES ASLAN Pharmaceuticals
04-Dec-2019 Micro-Leads Announces $10M in Funding for Precision Neuromodulation Therapy Albany Med
04-Dec-2019 Volker Koscielny, new Chief Medical Officer and new member of the Management Board at Almirall Almirall
04-Dec-2019 Interview Released Stefan Przyborski, Chairman for SMi’s 3D Cell Culture Conference 2020 SMi Group
04-Dec-2019 Chiesi outlines €350 million investment and announces the development of the first carbon minimal pressurised Metered Dose Inhaler (pMDI) for Asthma and COPD Chiesi Group
04-Dec-2019 Kancera reports in-depth analysis of the Phase Ib program with KAND567, showing the desired effect on the human immune system Kancera AB
04-Dec-2019 MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs MaxCyte, Inc.
04-Dec-2019 Aqilion strengthens its portfolio with two innovative pharmaceutical projects in the fields of inflammation and oncology AQILION AB
04-Dec-2019 MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs MaxCyte
04-Dec-2019 Developing Dementia Diagnostic Test Domestically in Japan with Retinal Imaging AI - Partnership Concluded with Canadian Optina Diagnostics to Build a Business in the Japanese Market Optina Diagnostics
04-Dec-2019 Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market Visiongain
04-Dec-2019 CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications CASI Pharmaceuticals, Inc.